Skip to content

KORU Medical Systems KRMD State Research Credit Carryforward

State Research Credit Carryforward at other companies

Motorcar Parts of America logo
Motorcar Parts of AmericaMPAA
$114K-90.1%
Syntec Optics Holdings, Inc. logo
Syntec Optics Holdings, Inc.OPTX
$740.87K+8.2%
Aptera Motors Corp.
 logo
Aptera Motors Corp. SEV
$3.87M+24.1%
AZZ logo
AZZAZZ
$970K-80.8%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$850K+49.9%
OS Therapies logo
OS TherapiesOSTX
$268.57K0.0%

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept krmd:StateResearchCreditCarryforward.

The official record: KORU Medical Systems’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's state research credit carryforward.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's state research credit carryforward?
KORU Medical Systems (KRMD) reported state research credit carryforward of $0 in Q4 2025.
What does state research credit carryforward mean?
This represents the portion of state-level tax credits earned through research and development activities that remains unused and available to reduce future state income tax liabilities. It highlights the geographic footprint of the company's R&D operations and the utilization of state-specific incentives for technological advancement. Tracking this helps investors understand the potential for state tax savings as the company scales its product portfolio.